Back to mobile site
Get it on Google Play

PharmaTher partners with KetaMist inventor to seek FDA approval

July 21, 2026 8:02 AM EDT Send to a Friend
PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) announced a collaboration with Curtis W. Cassidy, M.D., the developer of KetaMist, a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login